Expression of TGFα, EGF, and EGFR worsens prognosis and increases the metastatic potential of breast [34], renal [35], and colorectal cancers [36], all known to be obesity-associated malignancies. Here, EGFR is linked to obesity due to melanocortin 4 receptor deficiency.